United States · Funded startup

Who invested in Beam Therapeutics

3 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$322Mraised across 3 rounds since 2018, from 3 sources

$87MSeries A$135MSeries B$100MDebt
Latest round
Debt, $100MFeb 2026
Biggest round
$135MSeries B · Mar 2019
Investors
12
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026
$87MSeries A$135MSeries B$100MDebt
First round
Series A, $87M
May 2018
Biggest round
$135M
Series B · Mar 2019
Usual gap between rounds
6.9 years
the median of 2

The rounds

  1. Feb 2026
  2. Mar 2019
    Series B$135M7 new1 returning

    Reported by FinSMEsSEC filing: $84M sold, first sale Feb 2018

  3. May 2018
    Series A$87M2 new

    Reported by FinSMEsSEC filing: $45M sold, first sale Feb 2018

Founders and team

From Beam Therapeutics's own website and the SEC filings it signed: 8 on the team.

  • John EvansChief Executive Officer and Board Member
  • Eric FosterChief Commercial Officer
  • Sravan EmanyChief Financial Officer
  • Susan O’ConnorChief Human Resources Officer
  • Chirfi GuindoBoard Member
  • Christi ShawBoard Member
  • Graham CooperBoard Member
  • Kate WalshBoard Member

On the board, as filediCarole HoKristina BurowMark FishmanMichael YiRobert NelsenStephen Knight

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

ARCH Venture PartnersVC firm2rounds
F-Prime CapitalVC firm2rounds
Redmile GroupVC firm2rounds
Omega FundsVC firm2rounds
Google VenturesCorporate VC1round
Perceptive AdvisorsAsset manager1round
Cormorant Asset ManagementPrivate equity1round
Foresite CapitalPrivate equity1round
ArchHedge fund1round
Cormorant Assetno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Beam Therapeutics

Who invested in Beam Therapeutics?

Beam Therapeutics's investors include ARCH Venture Partners, F-Prime Capital, Redmile Group, Omega Funds and Google Ventures, and 7 more on record.

How much has Beam Therapeutics raised?

Beam Therapeutics has raised $322M across 3 rounds since 2018.

When did Beam Therapeutics last raise?

Beam Therapeutics's most recent round was a Debt of $100M in Feb 2026.

What was Beam Therapeutics's biggest round?

Beam Therapeutics's largest round on record is $135M (Series B), in Mar 2019.

Who backed Beam Therapeutics first?

Beam Therapeutics's first round on record, in May 2018, was backed by ARCH Venture Partners and F-Prime Capital.

What stage is Beam Therapeutics at?

Beam Therapeutics's latest named round is a Debt, in Feb 2026.

Where is Beam Therapeutics based?

Beam Therapeutics is based in the United States.

Companies like Beam Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.